Aging clinical trials
Showing 51–84 of 84 active trials. Describe your situation to see which ones look like a fit.
- Targeting Aging With a Ketone Ester for Function in Frailty
- Healthy Lifetime - Phase 2
- Identification of Critical Thermal Environments for Aged Adults
- Ketone Ester And Salt (KEAS) in Older Adults
- Aging, Beta Blockers, and Thermoregulatory Responses
- Multimodal Musical Stimulation for Healthy Neurocognitive Aging
- Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
- The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
- Neurobiological Mechanisms of Aging and Stress on Prospective Navigation
- The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
- Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
- Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal Women
- Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris
- IMAT Quality in Aging
- Emotion, Aging, and Decision Making
- The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging
- Cardiorespiratory Fitness and Acute High-Intensity Exercise Effects on Brain and Cognitive Function in Older Adults
- Ecological Momentary Cognitive Assessment
- Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
- Vagus Nerve Stimulation to Enhance Memory in Aging
- Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study
- Implementation of Routine Walking Speed Measurements in Older Veterans
- PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study
- Application of the Modified Story Memory Technique (mSMT)© to Aging
- Iterative Design Trial to Assess Dietary Supplements and Other Aging-targeted Therapies
- PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study (PUER) in Ages 6 Through 18
- Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults
- Effects of Asymmetries on Binaural-Hearing Abilities Across the Lifespan
- Transient Receptor Potential Channels
- Effect of Snacks on Aging
- Brain Health Virtual Reality Study
- Heat, Microvascular Function and Aging
- A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
- AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.